IPO Plus

BSE · 543207

Natural Biocon (India) Limited

3.43
₹9 Cr market cap
P/E
EPS
₹0
Book value
₹11.92
ROE
-13.02%
ROCE
-0.13%
Debt / equity
0.01

Revenue & net profit by period

Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.

03.386.7710.1513.53Mar 18Mar 19Mar 20Mar 21Mar 22Mar 23Mar 24Mar 25
Revenue (₹ Cr) Net profit (₹ Cr)

Latest period: revenue ₹8 Cr with net profit ₹0 Cr — a 0.53% net margin, versus 1.13% the period before.

Shareholding

As of 2026-06-30

9.36%
promoter holding
  • Promoter9.36%
  • Public90.64%

11,352 shareholders on record

Promoter holding trend

Each disclosed period, oldest to newest

9.36%9.36%Sep 24Jun 26

52-week position

Where the current price sits in its yearly band

3.043.4313.44

The band spans 4.42× from low to high.

Risk flags

Derived from disclosed data

No flags raised by the data.

Peer comparison

Trading · ranked #447 of 666 by market cap · medians across 50 industry peers

P/E
vs 103.39 peer med
P/B
0.29vs 5.13 peer med
ROE %
-13.02vs 12.48 peer med
Margin %
-117.65vs 4.65 peer med
CompanyMkt capP/EP/BROEMargin
Adani Enterprises Limited₹4,09,340 Cr24.354.323.42%9.3%
Avenue Supermarts Limited₹2,50,959 Cr381.3810.2612.14%4.32%
Trent Ltd.₹1,60,247 Cr92.8422.9424.62%8.57%
FSN E-Commerce Ventures Ltd.₹93,790 Cr1212.9665.2113.87%1.99%
Vishal Mega Mart Limited₹50,703 Cr56.976.8311.32%6.61%
Premier Energies Limited₹47,038 Cr102.1910.935.05%19.3%
Aegis Logistics Limited₹45,019 Cr109.727.4414.83%10.78%
Aditya Infotech Limited₹40,364 Cr238.3421.4819.61%8.72%
Redington Limited₹22,472 Cr57.382.2114.67%1.25%
Honasa Consumer Limited₹14,620 Cr210.9610.3614.16%8.36%
Natural Biocon (India) Limited(this company)₹9 Cr0.29-13.02%-1.18%

AI analysis

AI-generated · google/gemini-2.5-flash

Natural Biocon (India) Limited is listed with a market capitalization of Rs 9 Cr. The company reported a negative profit margin of -117.65% and a return on equity (ROE) of -13.02%. The debt-to-equity ratio stands at 0.01.

Positives

  • +The company has a low debt-to-equity ratio of 0.01.
  • +Promoter holding of 9.36% has no shares pledged.

Negatives

  • The profit margin is negative at -117.65%.
  • Return on equity (ROE) is negative at -13.02%.
  • Return on capital employed (ROCE) is negative at -0.13%.
  • Promoter holding decreased from 28.96% in Mar 2021 to 9.36% in Mar 2026.
  • The company reported a net loss of Rs -0.09 Cr for the quarter ending Mar 2026.

Financial performance

The company's revenue has shown fluctuations, decreasing from Rs 13.53 Cr in Mar 2024 to Rs 8.35 Cr in Mar 2025. Net profit also declined from Rs 0.15 Cr in Mar 2024 to Rs 0.04 Cr in Mar 2025. Latest quarterly results as of Mar 2026 show a revenue of Rs 0.88 Cr and a net loss of Rs -0.09 Cr.

Profitability & returns

Natural Biocon (India) Limited reported negative profitability metrics. The return on equity (ROE) was -13.02%, and return on capital employed (ROCE) was -0.13%. The profit margin stood at -117.65%. Earnings per share (EPS) was 0 for the most recent period.

Balance sheet

The company maintains a low debt-to-equity ratio of 0.01, indicating minimal reliance on borrowed funds. The book value per share is Rs 11.92.

Ownership & pledges

As of Mar 2026, the promoter holding in Natural Biocon (India) Limited was 9.36%, with public shareholders holding 90.64%. There is no promoter pledging reported. The number of shareholders has significantly increased to 11027 from 581 in Mar 2020.

Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.

How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.

Back to Natural Biocon (India) Limitedshare price & fundamentals

Telegram App